CPT code 85260: Factor X, stuart-Prower activity2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Measures factor X activity for evaluation of suspected Stuart-Prower factor deficiency or other clinically indicated coagulation concerns.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide2K Medicare services in 2024

Medicare pays $17.90 for 85260 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$17.90

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 7 sections
  1. Medicare lab fee
  2. What 85260 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Billing questions
  7. Sources

What 85260 covers

Factor X activity testing assesses the function of Stuart-Prower factor, a coagulation protein in the common pathway. Clinicians may order it when investigating suspected inherited or acquired factor X deficiency, bleeding, or unexplained abnormalities in coagulation studies. A coagulation laboratory generally performs the assay on citrated plasma; hematologists and other clinicians interpret the result alongside the patient’s history and other coagulation tests.

Report 85260 for the factor X activity assay itself, rather than another factor assay or a general coagulation screen. Medicare pays the laboratory service under the CLFS: the 2026 national amount is $17.90, unchanged from 2020 through 2026. The same amount applies in every state and locality, without geographic or office/facility adjustment. Medicare pays this code only through the CLFS, not the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 85260

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 85260. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 85260 with status X (excluded by statute), so the test itself is paid only from the CLFS.

85260 on the lab fee schedule since 2020

85260 · CLFS 2026 Q4 (current)

$17.90

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

85260 compared with similar tests

85210Factor II assayProthrombin measurement$12.98
Use 85210 for a factor II assay; 85260 is specific to factor X activity.
85230Factor VII assayProconvertin activity$17.90
Use 85230 for a factor VII assay. The ordered factor determines which code applies.
85270Factor XI assayFactor XI (PTA)$17.90
Use 85270 for a factor XI assay; 85260 reports factor X activity.

85260 billing questions

When should 85260 be selected instead of another coagulation factor assay?

Use 85260 when the requested test measures factor X activity. Select a different factor code when the order is for another specific coagulation factor.

What specimen is used for the assay?

The assay is generally performed on citrated plasma.

Is modifier 26 appropriate for Medicare billing?

No. Medicare pays 85260 through the CLFS, not the physician fee schedule, so it is not separately payable under the physician fee schedule with modifier 26.

What clinical documentation supports the test?

Documentation should identify the clinical reason for assessing factor X activity, such as suspected factor X deficiency, bleeding, or abnormal coagulation results.

How does Medicare pay for 85260?

Medicare pays 85260 under the CLFS at one national amount that applies across localities and settings.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 85260PUF_CLFS_CY2026_Q4V1.csv, line 1,558 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 85260?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 85260 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist